These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Provisional CDC guidelines for the use and safety monitoring of bedaquiline fumarate (Sirturo) for the treatment of multidrug-resistant tuberculosis. Centers for Disease Control and Prevention. MMWR Recomm Rep; 2013 Oct 25; 62(RR-09):1-12. PubMed ID: 24157696 [Abstract] [Full Text] [Related]
26. Delamanid for multidrug-resistant pulmonary tuberculosis. Gler MT, Skripconoka V, Sanchez-Garavito E, Xiao H, Cabrera-Rivero JL, Vargas-Vasquez DE, Gao M, Awad M, Park SK, Shim TS, Suh GY, Danilovits M, Ogata H, Kurve A, Chang J, Suzuki K, Tupasi T, Koh WJ, Seaworth B, Geiter LJ, Wells CD. N Engl J Med; 2012 Jun 07; 366(23):2151-60. PubMed ID: 22670901 [Abstract] [Full Text] [Related]
27. Randomized trial of adjunctive interleukin-2 in adults with pulmonary tuberculosis. Johnson JL, Ssekasanvu E, Okwera A, Mayanja H, Hirsch CS, Nakibali JG, Jankus DD, Eisenach KD, Boom WH, Ellner JJ, Mugerwa RD, Uganda-Case Western Reserve University Research Collaboration. Am J Respir Crit Care Med; 2003 Jul 15; 168(2):185-91. PubMed ID: 12702550 [Abstract] [Full Text] [Related]
28. Treatment of multidrug-resistant pulmonary tuberculosis with interferon-gamma via aerosol. Condos R, Rom WN, Schluger NW. Lancet; 1997 May 24; 349(9064):1513-5. PubMed ID: 9167461 [Abstract] [Full Text] [Related]
31. Double-blind placebo-controlled trial of Mycobacterium vaccae immunotherapy for tuberculosis in KwaZulu, South Africa, 1991-97. Mayo RE, Stanford JL. Trans R Soc Trop Med Hyg; 2000 May 24; 94(5):563-8. PubMed ID: 11132390 [Abstract] [Full Text] [Related]
32. Effect of oral immunomodulator Dzherelo in TB/HIV co-infected patients receiving anti-tuberculosis therapy under DOTS. Nikolaeva LG, Maystat TV, Pylypchuk VS, Volyanskii YL, Masyuk LA, Kutsyna GA. Int Immunopharmacol; 2008 Jun 24; 8(6):845-51. PubMed ID: 18442788 [Abstract] [Full Text] [Related]
34. Computed tomography features of extensively drug-resistant pulmonary tuberculosis in non-HIV-infected patients. Lee ES, Park CM, Goo JM, Yim JJ, Kim HR, Lee HJ, Lee IS, Im JG. J Comput Assist Tomogr; 2010 Jul 24; 34(4):559-63. PubMed ID: 20657225 [Abstract] [Full Text] [Related]
36. Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial. Wejse C, Gomes VF, Rabna P, Gustafson P, Aaby P, Lisse IM, Andersen PL, Glerup H, Sodemann M. Am J Respir Crit Care Med; 2009 May 01; 179(9):843-50. PubMed ID: 19179490 [Abstract] [Full Text] [Related]
37. CD4(+)FoxP3(+) T regulatory cells in drug-susceptible and multidrug-resistant tuberculosis. Lim HJ, Park JS, Cho YJ, Yoon HI, Park KU, Lee CT, Lee JH. Tuberculosis (Edinb); 2013 Sep 01; 93(5):523-8. PubMed ID: 23810735 [Abstract] [Full Text] [Related]
38. Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis. Pym AS, Diacon AH, Tang SJ, Conradie F, Danilovits M, Chuchottaworn C, Vasilyeva I, Andries K, Bakare N, De Marez T, Haxaire-Theeuwes M, Lounis N, Meyvisch P, Van Baelen B, van Heeswijk RP, Dannemann B, TMC207-C209 Study Group. Eur Respir J; 2016 Feb 01; 47(2):564-74. PubMed ID: 26647431 [Abstract] [Full Text] [Related]